Thymidylate synthase haplotype is associated with tumor...

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/68 (2006.01)

Patent

CA 2727247

The invention provides compositions and methods for determining the likelihood of tumor recurrence following treatment with 5-FU based adjuvant therapy for Stage II or Stage III colon cancer patients. After determining if a patient is less likely to experience tumor recurrence once treated, the invention also provides methods for treating these patients.

L'invention concerne des compositions et des procédés pour déterminer la probabilité de récurrence tumorale après traitement par une thérapie d'appoint à base de 5-FU pour des patients atteints d'un cancer du côlon au stade II ou au stade III. Après avoir déterminé si un patient est moins susceptible de subir une récurrence tumorale une fois qu'il a été traité, l'invention propose également des procédés de traitement de ces patients.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Thymidylate synthase haplotype is associated with tumor... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Thymidylate synthase haplotype is associated with tumor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thymidylate synthase haplotype is associated with tumor... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1916864

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.